Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpharabi is a leading pharmaceutical manufacturer based in Syria, specializing in the production of a wide range of human and veterinary medicines. Established in 1994, the company operates extensive manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. Its human health portfolio encompasses diverse therapeutic areas, including anti-infectives, cardiovascular agents, and hormones, while its veterinary division provides essential vaccines and treatments for livestock. Alpharabi plays a critical role in the healthcare infrastructure of the Middle East and North Africa (MENA) region through both its branded generic products and contract manufacturing services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpharabi.